|
|
 |
Index |
|
|
| |
 BrightGene Bio-medical technology CO.,LTD is a fast-growing biopharmaceutical company that engages in the research, development and manufacturing of Active Pharmaceutical Ingredients and Intermediates with primary focus on the high-end API market and late-stage drug candidates. The Company has achieved revenue growth rate of over 100% annually since its establishment in 2001. It is now one of the most Distinguished Technology Businesses in the province of Jiangsu . It has been rewarded research grants by the Ministry of Science and Technology for innovative breakthroughs in a number of patented pharmaceutical intermediates.
Headquartered in the Center for New Medicine Discovery and Research in Suzhou , BrightGene is aggressively committed to the commercialization of the following leading products in its rapidly expanding pipeline:
- Entecavir and intermediates
- Posaconazole intermediates
- Fondaparinux sodium intermediate
- Lapatinib intermediates
- Pemetrexed disodium and intermediates
- Aliskiren intermediates
In addition, our commitment extends to delivering excellent products and services for clients around the globe and partnering with companies and institutions whose strength will augment our own. |
| |
|
